Self-Testing Market by Product Type (Pregnancy Test Kits, Blood Glucose Monitoring Devices, Ovulation Test Kits, COVID-19 Test Kits, Cholesterol Test Kits, HIV Test Kits, Urine Test Kits, Drug Abuse Test Kits), Technology (Lateral Flow Assay, Immunoassay, Enzyme-Linked Immunosorbent Assay (ELISA), Polymerase Chain Reaction (PCR), Biosensors), End-User (Home Care, Healthcare Facilities, Diagnostic Laboratories), and Region: Global Insights & Forecast (2023 – 2030)

As per Intent Market Research, the Self-Testing Market was valued at USD 20.8 Billion in 2024-e and will surpass USD 36.8 Billion by 2030; growing at a CAGR of 9.9% during 2025-2030.

The self-testing market is undergoing rapid expansion as consumers increasingly seek convenient, at-home solutions to monitor their health and well-being. With advancements in technology, a growing focus on preventive care, and a desire for privacy, self-testing products such as pregnancy test kits, blood glucose monitoring devices, and COVID-19 test kits have become widely accessible. These self-testing products not only cater to individual health monitoring but also ease the burden on healthcare systems by enabling users to conduct essential tests from the comfort of their homes. This trend is expected to continue, driven by a demand for quick, reliable, and easy-to-use diagnostic tools.

Pregnancy Test Kits Segment is Largest Owing to Widespread Use and Consumer Trust

Among the various product types in the self-testing market, pregnancy test kits remain the largest segment. Pregnancy test kits have been a staple in households for decades, offering women a convenient way to confirm pregnancy without the need for a doctor's visit. The widespread use and consumer trust in these products make them the dominant subsegment. Available in various formats, such as urine-based and digital tests, pregnancy kits provide quick and accurate results, which has bolstered their demand across global markets.

The simplicity, affordability, and reliability of pregnancy test kits have solidified their position as the largest subsegment within the self-testing market. As awareness and education about these tests increase, the demand continues to grow, particularly among younger, health-conscious individuals. Furthermore, the consistent need for pregnancy-related tests and the convenience of conducting them at home without the need for medical assistance continue to drive the popularity of this segment.

Biosensors Technology is Fastest Growing Owing to Innovations in Health Monitoring

In the technology segment, biosensors are the fastest-growing subsegment. These devices, which detect and measure biological signals, are revolutionizing self-testing by enabling highly accurate, real-time health monitoring. With the integration of advanced sensor technology and mobile applications, biosensors are paving the way for a new generation of self-testing devices, including those for blood glucose, cholesterol, and even COVID-19 monitoring. Their ability to provide continuous data for various health metrics has made them a preferred choice for both medical professionals and consumers.

The adoption of biosensors in self-testing devices is driven by their ability to offer more sophisticated and reliable results compared to traditional methods. For instance, continuous glucose monitors (CGMs) and other biosensor-based devices allow patients with chronic conditions to track their health in real-time. As technology advances, these devices are becoming smaller, more affordable, and easier to use, further contributing to the rapid growth of the biosensor subsegment in the self-testing market.

Home Care End-User is Largest Due to Convenience and Accessibility

The home care segment represents the largest end-user category in the self-testing market. The increasing preference for at-home healthcare solutions, combined with rising health awareness, has made home care the most significant driver of market demand. Consumers are increasingly choosing to conduct health tests at home for a variety of reasons, including convenience, privacy, and the ability to monitor health without needing to visit healthcare facilities. This trend is particularly prevalent in tests for pregnancy, glucose levels, cholesterol, and drug use, where individuals are more comfortable conducting the tests in a private setting.

The ease of purchasing self-testing kits online or from pharmacies has also contributed to the growth of the home care segment. With minimal technical skills required, many of these products offer easy-to-read results and user-friendly interfaces, making them accessible to a wide range of consumers. This shift toward home care is expected to continue as more people look for ways to actively manage their health at home, reducing healthcare costs and preventing potential issues through early detection.

North America is the Largest Region in the Self-Testing Market

North America holds the largest market share in the self-testing sector, driven by a highly developed healthcare system, advanced technology, and high consumer spending on health products. In the United States, a growing demand for at-home testing solutions is being fueled by increased awareness of preventive healthcare and the availability of innovative products. North American consumers are particularly receptive to self-testing due to the convenience it offers in managing personal health, especially in areas such as blood glucose monitoring, pregnancy testing, and COVID-19 detection.

Furthermore, the region's strong healthcare infrastructure, along with increasing adoption of mobile health apps and wearable devices, has accelerated the market's growth. With a large number of companies offering self-testing products and continuous innovations in technology, North America is expected to maintain its dominant position in the self-testing market over the coming years. The region’s high purchasing power and emphasis on wellness will continue to drive demand for self-testing solutions.

Competitive Landscape and Leading Companies in the Self-Testing Market

The self-testing market is highly competitive, with numerous leading players focusing on developing innovative and accurate self-testing devices. Major companies such as Abbott Laboratories, Roche Diagnostics, and Siemens Healthineers dominate the market with their diverse product offerings across different categories, including pregnancy tests, blood glucose monitors, and COVID-19 test kits. These companies leverage strong research and development (R&D) capabilities to introduce cutting-edge technologies like biosensors, lateral flow assays, and PCR-based testing devices.

Smaller players, such as OraSure Technologies and Quidel Corporation, have also made significant strides in the market by introducing rapid diagnostic tests, especially in the areas of HIV and infectious disease testing. Partnerships, mergers, and acquisitions are common in this space, as companies seek to expand their product portfolios and reach new markets. As the demand for self-testing devices continues to rise, competition is expected to intensify, with companies focusing on innovation, regulatory approvals, and expanding their distribution channels to meet consumer needs.

List of Leading Companies:

• Abbott Laboratories
• Roche Diagnostics
• Siemens Healthineers
• Johnson & Johnson
• Abbott Laboratories
• Bio-Rad Laboratories
• Thermo Fisher Scientific
• OraSure Technologies
• Quidel Corporation
• Medtronic
• BioMerieux
• AccuQuik
• Xiamen Boson Biotech
• Labcorp
• Becton Dickinson and Company

Recent Developments:

• Abbott Laboratories launched a new at-home COVID-19 testing kit with a faster result processing time, designed for home use to detect the virus in under 15 minutes.
• Roche Diagnostics received FDA approval for its new blood glucose monitoring system that integrates with mobile devices, providing real-time data for diabetes management.
• OraSure Technologies expanded its product line by introducing a rapid HIV self-testing kit that allows users to obtain results within 20 minutes with high accuracy.
• Quidel Corporation announced a merger with another diagnostic firm to enhance its portfolio of self-testing products and broaden its distribution network.
• Siemens Healthineers unveiled a new point-of-care testing device aimed at improving self-testing for cardiovascular diseases, providing consumers with timely and reliable results.

Report Scope: